![Headquarters of US Food and Drug Administration (FDA)](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1286971245/image_1286971245.jpg?io=getty-c-w750)
Grandbrothers
Retractable Technologies (NYSE:RVP) its VanishPoint security syringes should not a part of a security advisory issued by the FDA on Thursday about suspected efficiency issues with sure syringes manufactured in China.
The firm mentioned that it has not made any current modifications to the product’s dimensions. It added that customers can proceed to be assured that its VanishPoint syringes ship right dosages and are in a position to shield customers from needlesticks.
On Thursday, the FDA mentioned that it was evaluating sure syringes made in China for potential breakage or leakage points that might influence efficiency.